Skip to main content

Advertisement

Log in

Optimization of A549 Cell Transfection Efficiency with a Plasmid Encoding the N-Protein of the SARS-CoV-2 Virus

  • BIOCHEMISTRY, BIOPHYSICS, AND MOLECULAR BIOLOGY
  • Published:
Doklady Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract—

To test new antiviral drugs aimed at degrading the nucleocapsid protein (N-protein) of the SARS-CoV-2 virus, it is desirable to have cells expressing the N-protein, for which it is necessary to find conditions for the maximum achievable efficiency of cell transfection with a plasmid encoding this protein. For transfection, polyplexes were used consisting of a plasmid encoding the N-protein fused with the mRuby3 fluorescent protein and polyethyleneimine (PEI)-polyethylene glycol (PEG)-TAT peptide block copolymers. The dependence of the transfection efficiency of human lung adenocarcinoma A549 cells on the PEG/PEI and N/P ratios (the ratio of nitrogen in PEI to phosphate in DNA) was studied. Significant positive correlations were shown between transfection efficiency determined by flow cytometry, the N/P ratio, and the proportion of polyplexes sized 40–54 nm. The data obtained can serve as a basis for creating an animal model of lung cells transiently expressing the N protein of the SARS-CoV-2 virus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

REFERENCES

  1. Surjit, M. and Lal, S.K., Infect. Genet. Evol., 2008, vol. 8, pp. 397–405.

    Article  CAS  PubMed  Google Scholar 

  2. Wu, C. and Zheng, M., Preprint 2020020247, 2020.

  3. Prajapat, M., Sarma, P., Shekhar, N., et al., Indian J. Pharmacol., 2020, vol. 52, p. 56.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bestion, E., Halfon, P., Mezouar, S., et al., Viruses, 2022, vol. 14, p. 1507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ulasov, A.V., Khramtsov, Y.V., Trusov, G.A., et al., Mol. Ther., 2011, vol. 19, pp. 103–112.

    Article  CAS  PubMed  Google Scholar 

  6. Shahbazi, S., Haghighipour, N., Soleymani, S., et al., Biotechnol. Lett., 2018, vol. 40, pp. 923–931.

    Article  CAS  PubMed  Google Scholar 

  7. Hall, A., Lachelt, U., Bartek, J., et al., Mol. Ther., 2017, vol. 25, pp. 1476–1490.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Trusov, G.A., Ulasov, A.V., Beletskaia, E.A., et al., Dokl. Biochem. Biophys., 2011, vol. 437, pp. 77–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Perrine, T.D. and Landis, W.R., J. Polym. Sci., Part A, 1967, vol. 5, pp. 1993–2003.

    CAS  Google Scholar 

  10. Kunath, K., von Harpe, A., Petersen, H., et al., Pharm. Res., 2002, vol. 19, pp. 810–817.

    Article  CAS  PubMed  Google Scholar 

  11. Gong, X.W., Wei, D.Z., He, M.L., et al., Talanta, 2007, vol. 71, pp. 381–384.

    Article  CAS  PubMed  Google Scholar 

Download references

ACKNOWLEDGEMENTS

The experiments were carried out using equipment of the Core Facility of the Institute of Gene Biology of the Russian Academy of Sciences.

Funding

The study was supported by a grant from the Russian Science Foundation (project no. 24-14-00170).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. S. Sobolev.

Ethics declarations

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

This work does not contain any studies involving human and animal subjects.

CONFLICT OF INTEREST

The authors of this work declare that they have no conflicts of interest.

Additional information

Translated by M. Batrukova

Publisher’s Note.

Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

AI tools may have been used in the translation or editing of this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khramtsov, Y.V., Lupanova, T.N., Rosenkranz, A.A. et al. Optimization of A549 Cell Transfection Efficiency with a Plasmid Encoding the N-Protein of the SARS-CoV-2 Virus. Dokl Biochem Biophys (2025). https://doi.org/10.1134/S1607672924601136

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1134/S1607672924601136

Keywords: